Atrium Therapeutics, Inc.
- RNA
- NASDAQ
- Biotechnology
- RNA Therapeutics
- Cardiomyopathy Treatments
$7.61
Today −0.78%Quote Oct 19, 2026, 08:00 PM UTC
−14.97%over the last month
Max drawdown −17.5%From 1-month high −17.5%3 months −38.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Atrium Therapeutics
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
511
Founded
2025
Market value
$130.2M
Quote Oct 19
Analyst target
$25.00
+228.5% from here
Floor
$7.58
0.3% below price
Resistance
$7.90
3.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free